FHA
TVRD

Flagship Harbor Advisors’s Tvardi Therapeutics TVRD Stock Holding History

Flagship Harbor Advisors’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6
Closed -$2K – 1837
2020
Q3 		$2K Hold
6
– – ﹤0.01% 1773
2020
Q2 		$3K Hold
6
– – ﹤0.01% 1767
2020
Q1 		$3K Hold
6
– – ﹤0.01% 1592
2019
Q4 		$3K Hold
6
– – ﹤0.01% 1673
2019
Q3 		$3K Hold
6
– – ﹤0.01% 1639
2019
Q2 		$4K Hold
6
– – ﹤0.01% 1576
2019
Q1 		$3K Hold
6
– – ﹤0.01% 1631
2018
Q4 		$2K Hold
6
– – ﹤0.01% 1683
2018
Q3 		$5K Hold
6
– – ﹤0.01% 1715
2018
Q2 		$3K Buy
+6
New +$3.05K ﹤0.01% 1806

Other funds holding TVRD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.17B AUM 42.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Flagship Harbor Advisors's TVRD Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Tvardi Therapeutics (TVRD) in Q4 2020, closing a stake of 6 shares — an estimated $2K sold.

Flagship Harbor Advisors first reported a position in TVRD in Q2 2018 and held it in 10 quarters. The position peaked at $5K in Q3 2018. 156 funds tracked by Wall St. Rank hold TVRD as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining Tvardi Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 6 Tvardi Therapeutics shares in Q4 2020, an estimated $2K.
  • Flagship Harbor Advisors first reported a position in Tvardi Therapeutics in Q2 2018 and held it in 10 quarters.
  • Flagship Harbor Advisors's Tvardi Therapeutics position peaked at $5K in Q3 2018.
  • 156 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.